ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756053; 2) Community: the network communities that were significantly associated with the response to NSC 756053; 3) Molecule: the relationships between components within communities and NSC 756053; 4) MDR: the compounds that were significantly associated with the NSC 756053.

NSC Compound Enrichment Correlation
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.00970780973624031 -0.32496393
NSC 638441 Null 0.00970780973624031 -0.23699117
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.00970780973624031 -0.35859681
NSC 658368 Null 0.00970780973624031 -0.33226041
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.00970780973624031 -0.42272937
NSC 675766 Null 0.00970780973624031 0.37537571
NSC 676395 Cyclobutanemethanol, 1-[[(2-amino-4-chloro-5-[(4-chlorophenyl)azo]- 6-pyrimidinyl)amino]methyl]-3-(3-phenylmethoxy)- 0.00970780973624031 -0.12300387
NSC 681635 Camptothecin Derivative 0.00970780973624031 -0.065339645
NSC 682881 Null 0.00970780973624031 0.018740261
NSC 691577 Null 0.00970780973624031 -0.19367236
Total:76  Current:15    [First] [Prev] [Next] [Last]